| 2021-06-10 | Sale | Illumina, Inc. ILMN | director | 1,000 0.0007% | $450.00 | $450,000 | -15.8% | |
| 2021-04-05 | Sale | Intellia Therapeutics, Inc. NTLA | director | 7,500 0.0113% | $82.19 | $616,405 | +40.33% | |
| 2016-09-22 | Sale | Biogen Inc. BIIB | director | 55,140 0.0251% | $314.00 | $17.31M | -9.56% | |
| 2015-08-05 | Sale | Public Service Enterprise Group Incorporated PEG | Executive VP & CFO | 47,091 0.0093% | $41.14 | $1.94M | +5.56% | |
| 2015-08-04 | Sale | Public Service Enterprise Group Incorporated PEG | Executive VP & CFO | 80,309 0.0161% | $41.10 | $3.3M | +6.83% | |
| 2014-03-20 | Sale | Biogen Inc. BIIB | director | 20,000 0.0085% | $348.88 | $6.98M | -6.39% | |
| 2013-10-31 | Public Service Enterprise Group Incorporated PEG | Executive VP & CFO | 1,000 0.0002% | $33.04 | $33,037 | +13.68% | ||
| 2012-05-22 | Public Service Enterprise Group Incorporated PEG | director | 3,400 0.0007% | $30.94 | $105,186 | +5.42% | ||
| 2011-08-09 | Public Service Enterprise Group Incorporated PEG | director | 2,000 0.0004% | $29.17 | $58,340 | +9.43% | ||
| 2010-08-13 | Biogen Inc. BIIB | director | 177 <0.0001% | $56.41 | $9,985 | +20.92% | ||
| 2010-07-30 | Biogen Inc. BIIB | director | 183 <0.0001% | $54.57 | $9,986 | +20.33% | ||
| 2010-07-16 | Biogen Inc. BIIB | director | 185 <0.0001% | $53.71 | $9,936 | +29.2% | ||
| 2010-06-30 | Biogen Inc. BIIB | director | 205 <0.0001% | $48.63 | $9,970 | +40.44% | ||
| 2010-06-18 | Biogen Inc. BIIB | director | 203 <0.0001% | $49.15 | $9,977 | +32.58% | ||
| 2010-05-28 | Biogen Inc. BIIB | director | 208 <0.0001% | $48.01 | $9,986 | +37.39% | ||
| 2010-05-14 | Biogen Inc. BIIB | director | 195 <0.0001% | $51.19 | $9,982 | +27.97% | ||
| 2010-04-30 | Biogen Inc. BIIB | director | 187 <0.0001% | $53.38 | $9,982 | +17.33% | ||
| 2010-03-01 | Public Service Enterprise Group Incorporated PEG | Executive V.P. & CFO - PSEG | 4,000 0.0008% | $29.94 | $119,760 | +8.17% | ||
| 2004-02-27 | Public Service Enterprise Group Incorporated PEG | director | 400 0.0002% | $46.92 | $18,767 | -5.49% |